Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
MD Anderson cancer center
Sep 12, 2023, 15:07 |
Blog
Lucia Masarova: Excited about this excellent meeting - always one of the best discussions and engagements on the topic.
Lucia Masarova, Assistant Professor, Department of Leukemia at MD Anderson Cancer Center, shared a post…
Sep 9, 2023, 20:34 |
Blog
Jorge Cortes: It is an honor to receive this award named after a giant in leukemia research and a great mentor to me by another giant and mentor Hagop Kantarjian at the Society of Hematologic Oncology (SOHO).
Sep 9, 2023, 08:15 |
Positive
100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 3
On August 26th, which marks Women's Equality Day in the United States, OncoDaily began featuring…
Sep 8, 2023, 16:13 |
Societies
Naveen Pemmaraju: Delighted to be recognized by the Society of Hematologic Oncology for the Honorable Distinction Award
Naveen Pemmaraju, Leukemia Professor at the MD Anderson Cancer Center, shared on his Twitter account:…
Sep 7, 2023, 20:02 |
Societies
Naveen Pemmaraju: And SOHO23 week here in Houston Society of Hematology/Oncology begins!
Naveen Pemmaraju, Director of Department of Leukemia at MD Anderson Cancer Center, shared on Twitter:…
Sep 3, 2023, 17:31 |
Insight
Jayastu Senapati: A small effort highlighting the challenges in the care of patients with AML in LMICs - The Lancet Haematology
Jayastu Senapati, a clinical fellow, at MD Anderson Cancer Center, recently tweeted: "A small effort…
Sep 3, 2023, 17:25 |
Insight
Sangeeta Goswami: Some publications are extra special because of the emotional value attached to it.
Sangeeta Goswami, Assistant Professor at the MD Anderson Cancer Center, recently tweeted: "Some publications are…
Sep 2, 2023, 19:00 |
Opinion
Naveen Pemmaraju: Please join us for a special episode of Heme Reports!
Naveen Pemmaraju, the Director of the Leukemia - Cancer Network at the MD Anderson Cancer Center,…
Sep 1, 2023, 18:38 |
Drugs
Hagop Kantarjian: Now out in American Journal of Hematology reporting Ph II trial of CLIA +/- Sorafenib in newly diagnosed AML.
Hagop Kantarjian, Department Chair, Department of Leukemia, Division of Cancer Medicine at MD Anderson Cancer…
Aug 31, 2023, 19:04 |
Insight
Naveen Pemmaraju: Ph2 CLIA with or without sorafenib for upfront AML therapy.
Naveen Pemmaraju, the Executive Director of Cancer Medicine at the MD Anderson Cancer Center, recently…
118
119
120
121
122
All:
1251
Posts:
1191 - 1200
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube